查找临床试验
已按「骨髓纤维化」检索，对应国际通用词 myelofibrosis
共找到 18 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
United States、Australia、Belgium、Bulgaria、Canada 等 12 国
年龄 18 Years – 不限
Celgene
Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
Hong Kong
年龄 18 Years – 不限
The University of Hong Kong
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects
China
年龄 18 Years – 75 Years
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
China
年龄 18 Years – 不限
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Takeda
A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis
China
年龄 18 Years – 不限
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
United States、Australia、Hong Kong、Italy、New Zealand 等 6 国
年龄 18 Years – 不限
Merck Sharp & Dohme LLC
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Novartis Pharmaceuticals
A Study of GLB-001 in Patients With Myeloid Malignancies
China
年龄 18 Years – 不限
Hangzhou GluBio Pharmaceutical Co., Ltd.
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xiamen University
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
United States、Belgium、Bulgaria、Canada、Czechia 等 12 国
年龄 18 Years – 不限
Karyopharm Therapeutics Inc
Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis
China
年龄 18 Days – 不限
Henan Cancer Hospital